🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Retinopathy

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD) NCT07502664n/a1 site📍 Irvine Ray Therapeutics, Inc. Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Robotic RVO Trial: Robot-assisted Retinal Vein Cannulation in Patients With Retinal Vein Occlusions NCT07820761NA1 site📍 Oxford University of Oxford · Tests: Surgery with Preceyes Robot plus NHS standard of care Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study NCT07821450n/a1 site📍 Istanbul Abdulkadir Küçük · Tests: Repeated intravitreal anti-VEGF injection with eyelid speculum Prevention of ProliFerative Vitreoretinopathy With Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial NCT06541574Phase 21 site📍 Cincinnati Cincinnati Eye Institute, Southwest Ohio · Tests: Methotrexate Injection, Methotrexate Infusion, Sham Injection AVIGA3 (Cohort 2.0) NCT07255859NA1 site📍 Singapore Tan Tock Seng Hospital · Tests: Amsler Grid, AVIGA High Resolution Imaging OCT Study NCT07338461NA1 site📍 Milan Heidelberg Engineering GmbH · Tests: Autofluorescence Imaging, Infrared reflectance imaging, OCT imaging, OCTA imaging Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease NCT07439887Phase 1, Phase 23 sites📍 Bakersfield📍 Pittsburgh📍 Bellaire Ray Therapeutics, Inc. · Tests: RTx-021 Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD) NCT05803785Phase 12 sites📍 Sydney📍 Sydney Benobio Co., Ltd. · Tests: BBC1501 Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium NCT04008121EARLY Phase 11 site📍 Ann Arbor MediBeacon · Tests: Fluorescein sodium and Zeiss FF450 fundus camera, MB-102 and Zeiss FF450 fundus camera, Fluorescein sodium and commerci… Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery NCT07178639NA1 site📍 Kolín Nemocnice Kolín · Tests: Bromfenac 0.09 % Ophthalmic Solution, Nepafenac 0.3% Oph Susp, diclofenac 0.1% ophthalmic susp. Long-term Clinical Outcomes After Retinal Artery Occlusion NCT07482228n/a1 site📍 Gwangju Chonnam National University Hospital · Tests: retinal artery occlusion Effect of Video Viewing on Intravitreal Injection Experience NCT07002372NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Procedure video viewing A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions NCT07734064Phase 14 sites📍 Phoenix📍 Southaven📍 Cincinnati Astellas Institute for Regenerative Medicine · Tests: ASP2020 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy NCT06817265Phase 330 sites📍 Xuancheng📍 Beijing📍 Guangzhou Beletalent (Zhuhai) Pharmaceutical Co., Ltd · Tests: TNTL, TNTL simulation preparation A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD NCT06346600n/a10 sites📍 Boston📍 Katy📍 Norfolk Skyline Therapeutics · Tests: SKG0106 Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration NCT04339764Phase 1, Phase 22 sites📍 Baltimore📍 Bethesda National Eye Institute (NEI) · Tests: iPSC-derived RPE/PLGA transplantation An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK) NCT06315556n/a1 site📍 Multiple Locations Bayer · Tests: Aflibercept (Eylea) Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting NCT05093374Phase 41 site📍 Vienna Medical University of Vienna · Tests: anti-VEGF agent, anti-VEGF agent Ethical Issues of Using Gene Therapy in the Treatment of AMD NCT07004361n/a1 site📍 Nantes Nantes University Hospital Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration NCT07064759Phase 3126 sites📍 Scottsdale📍 Sun City📍 Tucson 4D Molecular Therapeutics · Tests: 4D-150 IVT (3E10 vg/eye), EYLEA® (aflibercept) Injection 2 mg (0.05mL) Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration NCT04040205Phase 24 sites📍 Jacksonville📍 Iowa City📍 St Louis Medical College of Wisconsin · Tests: Abemaciclib Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa NCT06591793Phase 1, Phase 23 sites📍 Naples📍 London📍 London AAVantgarde Bio Srl · Tests: AAVB-081 Sleep, Diabetic Retinopathy and Melatonin NCT04547439Phase 21 site📍 Chicago University of Illinois Chicago · Tests: Melatonin, Placebo Study of ALK-001 on the Progression of Stargardt Disease NCT07419334Phase 314 sites📍 Phoenix📍 Aurora📍 Gainesville Alkeus Pharmaceuticals, Inc. · Tests: ALK-001, Placebo Comparative Study of Decellularized Human Amniotic Membrane Hydrogel and Inverted Internal Limiting Membrane Flap in Idiopathic Large Macular Holes NCT06433284NA1 site📍 Nakhon Si Thammarat Walailak University · Tests: 25-gauge pars plana vitrectomy with inverted flap technique and SF6 tamponade, 25-gauge pars plana vitrectomy with comp… A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa NCT06891885Phase 1, Phase 22 sites📍 Boston📍 Minneapolis Sumitomo Pharma America, Inc. · Tests: DSP-3077 Retinal Sheet Cohort 1, DSP-3077 Retinal Sheet Cohort 2, DSP-3077 Retinal Sheet Cohort 3 Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice NCT07015034NA2 sites📍 Copenhagen📍 Køge University of Copenhagen · Tests: focus on vision impairment in older patients in general practice Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration NCT07587515Phase 1, Phase 27 sites📍 Beverly Hills📍 Modesto📍 Wake Forest Eyconis INC. · Tests: EYC-0305 A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants NCT07836452Phase 11 site📍 Melbourne City Therapeutics · Tests: CITY-RBP4, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy